LabSafe Metrics 

LabSafe Metrics uses AI to predict drug releases and reduce global medication shortages.

OWNER

Susanne Eisele Cobo (See Profile)


Sector

Digital Health

Stage

Development, market readiness, clinical trial

Country

Spain


The technology developed by LabSade uses AI and machine learning to predict and optimize the launch of new products

Prediction of drug launch from trial and during the drug lifecycle.

Prepare to adapt with a technology platform that is configurable & scalable so can integrate new data & analytics

Status

–

IP Type

Trade secret

Time

–

Countries

Coverage

Trade secret protection involves keeping the information secret and taking measures to prevent unauthorized disclosure of LabSafe Metrics’ technology.

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 7th of May 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar